Bioprinting Technology

A Current State-of-the-Art Review

Amer B. Dababneh, Ibrahim Tarik Ozbolat

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Bioprinting is an emerging technology for constructing and fabricating artificial tissue and organ constructs. This technology surpasses the traditional scaffold fabrication approach in tissue engineering (TE). Currently, there is a plethora of research being done on bioprinting technology and its potential as a future source for implants and full organ transplantation. This review paper overviews the current state of the art in bioprinting technology, describing the broad range of bioprinters and bioink used in preclinical studies. Distinctions between laser-, extrusion-, and inkjet-based bioprinting technologies along with appropriate and recommended bioinks are discussed. In addition, the current state of the art in bioprinter technology is reviewed with a focus on the commercial point of view. Current challenges and limitations are highlighted, and future directions for next-generation bioprinting technology are also presented.

Original languageEnglish (US)
Article number061016
JournalJournal of Manufacturing Science and Engineering, Transactions of the ASME
Volume136
Issue number6
DOIs
StatePublished - Dec 1 2014

Fingerprint

Transplantation (surgical)
Scaffolds (biology)
Tissue engineering
Extrusion
Tissue
Fabrication
Lasers

All Science Journal Classification (ASJC) codes

  • Control and Systems Engineering
  • Mechanical Engineering
  • Computer Science Applications
  • Industrial and Manufacturing Engineering

Cite this

@article{8e3f384d2286478bb10583dd0136c31e,
title = "Bioprinting Technology: A Current State-of-the-Art Review",
abstract = "Bioprinting is an emerging technology for constructing and fabricating artificial tissue and organ constructs. This technology surpasses the traditional scaffold fabrication approach in tissue engineering (TE). Currently, there is a plethora of research being done on bioprinting technology and its potential as a future source for implants and full organ transplantation. This review paper overviews the current state of the art in bioprinting technology, describing the broad range of bioprinters and bioink used in preclinical studies. Distinctions between laser-, extrusion-, and inkjet-based bioprinting technologies along with appropriate and recommended bioinks are discussed. In addition, the current state of the art in bioprinter technology is reviewed with a focus on the commercial point of view. Current challenges and limitations are highlighted, and future directions for next-generation bioprinting technology are also presented.",
author = "Dababneh, {Amer B.} and Ozbolat, {Ibrahim Tarik}",
year = "2014",
month = "12",
day = "1",
doi = "10.1115/1.4028512",
language = "English (US)",
volume = "136",
journal = "Journal of Manufacturing Science and Engineering, Transactions of the ASME",
issn = "1087-1357",
publisher = "American Society of Mechanical Engineers(ASME)",
number = "6",

}

Bioprinting Technology : A Current State-of-the-Art Review. / Dababneh, Amer B.; Ozbolat, Ibrahim Tarik.

In: Journal of Manufacturing Science and Engineering, Transactions of the ASME, Vol. 136, No. 6, 061016, 01.12.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Bioprinting Technology

T2 - A Current State-of-the-Art Review

AU - Dababneh, Amer B.

AU - Ozbolat, Ibrahim Tarik

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Bioprinting is an emerging technology for constructing and fabricating artificial tissue and organ constructs. This technology surpasses the traditional scaffold fabrication approach in tissue engineering (TE). Currently, there is a plethora of research being done on bioprinting technology and its potential as a future source for implants and full organ transplantation. This review paper overviews the current state of the art in bioprinting technology, describing the broad range of bioprinters and bioink used in preclinical studies. Distinctions between laser-, extrusion-, and inkjet-based bioprinting technologies along with appropriate and recommended bioinks are discussed. In addition, the current state of the art in bioprinter technology is reviewed with a focus on the commercial point of view. Current challenges and limitations are highlighted, and future directions for next-generation bioprinting technology are also presented.

AB - Bioprinting is an emerging technology for constructing and fabricating artificial tissue and organ constructs. This technology surpasses the traditional scaffold fabrication approach in tissue engineering (TE). Currently, there is a plethora of research being done on bioprinting technology and its potential as a future source for implants and full organ transplantation. This review paper overviews the current state of the art in bioprinting technology, describing the broad range of bioprinters and bioink used in preclinical studies. Distinctions between laser-, extrusion-, and inkjet-based bioprinting technologies along with appropriate and recommended bioinks are discussed. In addition, the current state of the art in bioprinter technology is reviewed with a focus on the commercial point of view. Current challenges and limitations are highlighted, and future directions for next-generation bioprinting technology are also presented.

UR - http://www.scopus.com/inward/record.url?scp=84924411549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924411549&partnerID=8YFLogxK

U2 - 10.1115/1.4028512

DO - 10.1115/1.4028512

M3 - Article

VL - 136

JO - Journal of Manufacturing Science and Engineering, Transactions of the ASME

JF - Journal of Manufacturing Science and Engineering, Transactions of the ASME

SN - 1087-1357

IS - 6

M1 - 061016

ER -